Brendan Delaney
2021
In 2021, Brendan Delaney earned a total compensation of $5.7M as Chief Operating Officer at Aadi Bioscience.
Compensation breakdown
| Non-Equity Incentive Plan | $81,810 |
|---|---|
| Option Awards | $5,491,827 |
| Salary | $136,615 |
| Total | $5,710,252 |
Delaney received $5.5M in option awards, accounting for 96% of the total pay in 2021.
Delaney also received $81.8K in non-equity incentive plan and $136.6K in salary.
Rankings
In 2021, Brendan Delaney's compensation ranked 2,224th out of 12,406 executives tracked by ExecPay. In other words, Delaney earned more than 82.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,224 out of 12,406 | 82nd |
Division Manufacturing | 869 out of 5,494 | 84th |
Major group Chemicals And Allied Products | 331 out of 2,369 | 86th |
Industry group Drugs | 286 out of 2,090 | 86th |
Industry Pharmaceutical Preparations | 184 out of 1,537 | 88th |
Source: SEC filing on April 26, 2022.
Delaney's colleagues
We found three more compensation records of executives who worked with Brendan Delaney at Aadi Bioscience in 2021.